03/28/2025 4:20 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2025 8:00 AM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/24/2025 8:00 AM | FibroGen (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 3:15 PM | FibroGen (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/07/2025 6:01 PM | DeLucia David (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 6:02 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 6:03 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/24/2025 4:19 PM | FibroGen (Filer)
| Form 424B5 | |
02/24/2025 4:22 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2025 6:00 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:49 PM | ARMISTICE CAPITAL, LLC (Filed by) FibroGen (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for FGEN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for FibroGen and its competitors with MarketBeat's FREE daily newsletter.
|
02/13/2025 5:24 PM | FibroGen (Subject) PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SCHEDULE 13G/A | |
01/10/2025 5:15 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2025 5:16 PM | DeLucia David (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 4:01 PM | DeLucia David (Reporting) FibroGen (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/16/2024 8:15 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 7:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 7:00 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 3:52 PM | ARMISTICE CAPITAL, LLC (Filed by) FibroGen (Subject)
| Form SC 13G/A | |
11/12/2024 1:33 PM | FibroGen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024 11:11 AM | FibroGen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/03/2024 3:05 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 7:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 7:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 7:00 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:05 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 4:10 PM | FibroGen (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/10/2024 11:15 PM | FibroGen (Filer)
| Form EFFECT | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) FibroGen (Subject)
| Form SC 13G/A | |
06/28/2024 4:08 PM | FibroGen (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/26/2024 7:00 AM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:30 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:30 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 5:37 PM | FibroGen (Issuer) Graham Juan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:00 PM | Chung Christine (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:12 PM | FibroGen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 7:00 PM | Blaug Suzanne (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | EDWARDS JEFFREY L (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | Brennan Aoife (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
This almost killed Elon Musk (chilling details emerge) (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
06/06/2024 7:00 PM | Cravatt Benjamin (Reporting) FibroGen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Lema Gerald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 7:00 PM | FibroGen (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:46 PM | FibroGen (Issuer) Wettig Thane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 8:55 PM | FibroGen (Filer)
| Form ARS | |
04/24/2024 4:01 PM | FibroGen (Filer)
| Form DEF 14A | |
04/24/2024 4:08 PM | FibroGen (Filer)
| Form DEFA14A | |
04/24/2024 3:15 PM | Adib Deyaa (Reporting) FibroGen (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |